Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07095868 |
| Title | Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Everest Medicines (Beijing) Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10022 | United States | Details |
| MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
| NEXT Oncology | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
| Hunan Cancer Hospital | RECRUITING | Changsha | Hunan | 410006 | China | Details |
| Nanjing Drum Tower Hospital | RECRUITING | Nanjing | Jiangsu | 210000 | China | Details |
| The First Affiliated Hospital With Nanjing Medical University | RECRUITING | Nanjing | Jiangsu | 210029 | China | Details |